These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 25963594)

  • 1. Magnesium and cardiovascular complications of chronic kidney disease.
    Massy ZA; Drüeke TB
    Nat Rev Nephrol; 2015 Jul; 11(7):432-42. PubMed ID: 25963594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Magnesium disorder and its clinical significance in chronic kidney disease].
    Okuno S
    Clin Calcium; 2012 Aug; 22(8):1243-9. PubMed ID: 22846361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal Of Arterial Disease by modulating Magnesium and Phosphate (ROADMAP-study): rationale and design of a randomized controlled trial assessing the effects of magnesium citrate supplementation and phosphate-binding therapy on arterial stiffness in moderate chronic kidney disease.
    Vermeulen EA; Eelderink C; Hoekstra T; van Ballegooijen AJ; Raijmakers P; Beulens JW; de Borst MH; Vervloet MG
    Trials; 2022 Sep; 23(1):769. PubMed ID: 36096824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Magnesium on the Phosphate Toxicity in Chronic Kidney Disease: Time for Intervention Studies.
    Sakaguchi Y; Hamano T; Isaka Y
    Nutrients; 2017 Feb; 9(2):. PubMed ID: 28178182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnesium - its role in CKD.
    M de Francisco AL; Rodríguez M
    Nefrologia; 2013; 33(3):389-99. PubMed ID: 23640095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnesium Administration in Chronic Kidney Disease.
    Vermeulen EA; Vervloet MG
    Nutrients; 2023 Jan; 15(3):. PubMed ID: 36771254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnesium-based interventions for normal kidney function and chronic kidney disease.
    Massy ZA; Nistor I; Apetrii M; Brandenburg VM; Bover J; Evenepoel P; Goldsmith D; Mazzaferro S; Urena-Torres P; Vervloet MG; Cozzolino M; Covic A; Era-Edta OB
    Magnes Res; 2016 Apr; 29(4):126-140. PubMed ID: 28007671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnesium: A Magic Bullet for Cardiovascular Disease in Chronic Kidney Disease?
    Leenders NHJ; Vervloet MG
    Nutrients; 2019 Feb; 11(2):. PubMed ID: 30813254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypomagnesemia, chronic kidney disease and cardiovascular mortality: pronounced association but unproven causation.
    Dousdampanis P; Trigka K; Fourtounas C
    Hemodial Int; 2014 Oct; 18(4):730-9. PubMed ID: 24641780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnesium in chronic kidney disease: challenges and opportunities.
    Kanbay M; Goldsmith D; Uyar ME; Turgut F; Covic A
    Blood Purif; 2010; 29(3):280-92. PubMed ID: 20090315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Magnesium: the missing link between kidneys and vessels?].
    Tran TA; Jaques D; Ponte B
    Rev Med Suisse; 2016 Feb; 12(507):404-7. PubMed ID: 27039606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Cardiovascular Markers in Chronic Kidney Disease.
    Chen SC; Huang JC; Su HM; Chiu YW; Chang JM; Hwang SJ; Chen HC
    Kidney Blood Press Res; 2018; 43(4):1388-1407. PubMed ID: 30153666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnesium and Progression of Chronic Kidney Disease: Benefits Beyond Cardiovascular Protection?
    Sakaguchi Y; Hamano T; Isaka Y
    Adv Chronic Kidney Dis; 2018 May; 25(3):274-280. PubMed ID: 29793667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats.
    Meng Y; Zhang H; Li Y; Li Q; Zuo L
    Bone; 2014 Jan; 58():168-76. PubMed ID: 24145307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between serum magnesium levels and cardiovascular events in chronic kidney disease patients.
    Kanbay M; Yilmaz MI; Apetrii M; Saglam M; Yaman H; Unal HU; Gok M; Caglar K; Oguz Y; Yenicesu M; Cetinkaya H; Eyileten T; Acikel C; Vural A; Covic A
    Am J Nephrol; 2012; 36(3):228-37. PubMed ID: 22948239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnesium and outcomes in patients with chronic kidney disease: focus on vascular calcification, atherosclerosis and survival.
    Massy ZA; Drüeke TB
    Clin Kidney J; 2012 Feb; 5(Suppl 1):i52-i61. PubMed ID: 26069821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnesium to prevent kidney disease-associated vascular calcification: crystal clear?
    Ter Braake AD; Vervloet MG; de Baaij JHF; Hoenderop JGJ
    Nephrol Dial Transplant; 2022 Feb; 37(3):421-429. PubMed ID: 33374019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Con: vascular calcification is a surrogate marker, but not the cause of ongoing vascular disease, and it is not a treatment target in chronic kidney disease.
    Zoccali C; London G
    Nephrol Dial Transplant; 2015 Mar; 30(3):352-7. PubMed ID: 25712936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma beta-2 microglobulin is associated with cardiovascular disease in uremic patients.
    Liabeuf S; Lenglet A; Desjardins L; Neirynck N; Glorieux G; Lemke HD; Vanholder R; Diouf M; Choukroun G; Massy ZA;
    Kidney Int; 2012 Dec; 82(12):1297-303. PubMed ID: 22895515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnesium and Vascular Calcification in Chronic Kidney Disease: Current Insights.
    Zaslow SJ; Oliveira-Paula GH; Chen W
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.